Is this email not displaying correctly? View it in your browser.
Customer Quarterly Newsletter | July 2014

Therapist Focus

Janet Milne

Janet Milne

How long have you been using the LTU-904:
I’ve been using the LTU-904 for 9 years now, and I initially trialled it as a lymphoedema practitioner for softening fibrosis, but when I read the manual I saw it’s applications for soft tissue problems and tried it on myself and family; I was so amazed at the results that I couldn’t give back the unit, so I now use it mainly in my massage practice to release the muscle trigger points, and have used it a lot on chronic unhealed ulcers.

Most inspiring or intriguing laser story:
There are so many inspiring and surprising laser stories that I don’t quite know where to start. 
I love that it “saves” my thumbs and hands so much as I don’t need to use a lot of pressure to release the trigger points, and I love that you can use it on someone with very delicate skin due to their age, perhaps on Warfarin, and can get deep into the muscle but without causing any adverse effects; so often clients say they’ve tried several other modalities of treatment and the LLLT has been the first one that has actually given them relief.

What do you use the laser for:
My daughters and I grab the LTU if we have a “zit” pop up and they know to make sure the unit’s fully wrapped in cling wrap.  I had a client come in for a massage with a nasty looking cold sore and “zapped” that for 1 minute, and couldn’t believe it when she said it disappeared in 2 days, where normally it would linger for ages.

Recently I took my mum with me to visit a client who had become a friend, and she told my mother that she felt she wouldn’t have been walking at all now, if it wasn’t for the laser treatment on her chronic ulcers.  When I first met her she had a 20+ year history of chronic ulcers, and had got to the stage where it was too painful to walk, with a deep ulcer on each lower leg.

As she also had lymphoedema she needed multilayer bandaging, which was applied daily to second daily after LLLT of ~ 3 joules to the ulcer and 1.5 j all around the periphery, on alternate days, gradually decreasing to weekly, then discontinued once healing was achieved.

It has been 3 years since she had any laser treatment and although she has been very lax in not wearing her compression stockings, the ulcer on her left leg has stayed healed, which I wouldn’t have thought possible, given her history.

I often think I don’t know what I would do without my “Lester”...I wonder how many others have named their LTU-904?

Important note

If your unit was supplied with a Reflective Shield, it is important that you ensure it is pulled off the tip rather than twisted when removing. If you find that it is stuck on: then with the tip pointed towards you, you may twist the shield slightly to the RIGHT ONLY while pulling it off.


To view some of our therapist videos with tips on laser application, head over to our You Tube channel here:

RianCorp's Presence

RianCorp strives to be present and current within the Low Level Laser and the Lymphoedema industries. We review and take part in the latest laser research; exhibit at various conferences within Australia, the United States, and New Zealand; and have regular workshops around Australia. To stay informed about the latest information, you can like us on Facebook, view the Events page on our website, or follow our You Tube channel.

New Research


Sheila H. Ridner, PhD, RN, FAAN, Ellen Poage-Hooper, MPH, MSN, NP-C, CLT-LANA, Collin Kanar, MD, Jennifer K. Doersam, BS, Stewart M. Bond, PhD, RN, AOCN, and Mary S. Dietrich, PhD


BACKGROUNDPURPOSE/OBJECTIVES: To examine the impact of advanced practice nurse (APN) administered low level laser therapy (LLLT) as both a stand-alone and complementary treatment for arm volume, symptoms, and quality of life (QOL) in women with breast cancer related lymphedema.

DESIGN: A three-group, pilot, randomized clinical trial.

SETTING: A private rehabilitation practice with two locations in the southwestern United States.

SAMPLE: 46 breast cancer survivors with treatment related lymphedema.

METHODS: Patients were screened for eligibility and then randomized to either manual lymphatic drainage (MLD) for 40 minutes, LLLT for 20 minutes, or, 20 minutes of MLD followed by 20 minutes of LLLT. Compression bandaging was applied after each treatment. Data were collected pre-treatment, daily, weekly, and at the end of treatment.

MAIN RESEARCH VARIABLES: Independent variables consisted of three types of APN administered lymphedema treatment. Outcome variables included limb volume, extracellular fluid, psychological and physical symptoms, and QOL.

FINDINGS: No statistically significant between group differences were found in volume reduction; however, all groups had clinically and statistically significant reduction in volume. No group differences were noted in psychological and physical symptoms, or QOL; however, treatment related improvements were noted in symptom burden within all groups. Skin improvement was noted in each group that received LLLT.

CONCLUSIONS: LLLT with bandaging may offer a time saving therapeutic option to conventional MLD. Alternatively compression bandaging alone could account for the demonstrated volume reduction.

IMPLICATIONS FOR NURSING: APNs can effectively treat lymphedema. APNs in private healthcare practices can serve as valuable research collaborators.

(Oncol Nurs Forum. Jul 2013; 40(4): 10.1188/13.ONF.383-393)

Full article available at:



Santos LA, Marcos RL, Tomazoni SS, Vanin AA, Antonialli FC, Grandinetti VD, Albuquerque-Pontes GM, de Paiva PR, Lopes-Martins RA, de Carvalho PD, Bjordal JM, Leal-Junior EC


This study aimed to evaluate the effects of low-level laser therapy (LLLT) immediately before tetanic contractions in skeletal muscle fatigue development and possible tissue damage. Male Wistar rats were divided into two control groups and nine active LLLT groups receiving one of three different laser doses (1, 3, and 10 J) with three different wavelengths (660, 830, and 905 nm) before six tetanic contractions induced by electrical stimulation. Skeletal muscle fatigue development was defined by the percentage (%) of the initial force of each contraction and time until 50 % decay of initial force, while total work was calculated for all six contractions combined. Blood and muscle samples were taken immediately after the sixth contraction. Several LLLT doses showed some positive effects on peak force and time to decay for one or more contractions, but in terms of total work, only 3 J/660 nm and 1 J/905 nm wavelengths prevented significantly (pā€‰<ā€‰0.05) the development of skeletal muscle fatigue. All doses with wavelengths of 905 nm but only the dose of 1 J with 660 nm wavelength decreased creatine kinase (CK) activity (pā€‰<ā€‰0.05). Qualitative assessment of morphology revealed lesser tissue damage in most LLLT-treated groups, with doses of 1-3 J/660 nm and 1, 3, and 10 J/905 nm providing the best results. Optimal doses of LLLT significantly delayed the development skeletal muscle performance and protected skeletal muscle tissue against damage. Our findings also demonstrate that optimal doses are partly wavelength specific and, consequently, must be differentiated to obtain optimal effects on development of skeletal muscle fatigue and tissue preservation. Our findings also lead us to think that the combined use of wavelengths at the same time can represent a therapeutic advantage in clinical settings.

(Lasers Med Sci. 2014 Mar 21)

Retrieved from:


Copyright © 2014, All rights reserved.
You're receiving this email because you are a valued customer of RianCorp, or you have opted in to our mailing list.

Our mailing address is: PO Box 177, Marleston, SA 5033 Australia